H emopexin (Hx) is an acute-phase protein synthesized by hepatocytes. Systemic concentration of Hx increases several-fold in response to the proinflammatory cytokines IL-6, IL-1b, and TNF-a (1). Other than in plasma, Hx is also expressed in human and mouse brain and in the neural retina (1) (2) (3) (4) (5) , and it can also be induced in peripheral nerves in response to injury (6) (7) (8) . Moreover, Hx has been found in human cerebrospinal fluid both in physiologic and pathologic conditions (9, 10) . Hx binds to free heme with high affinity (K d ,1 pM), and by scavenging heme from the bloodstream, it prevents heme-mediated endothelial and tissue damage (11) . Moreover, recent works demonstrated an anti-inflammatory role for Hx through its ability to modulate the expression of proinflammatory cytokines both in a heme-dependent and -independent way (12, 13) .
In humans, Hx has been chosen as a potential blood biomarker in pediatric multiple sclerosis (MS) (14) likely because of its role in the acute phase of inflammation. MS is a chronic inflammatory disease of the CNS mainly characterized by intervals of remission followed by relapse (15) (16) (17) . However, acute progressive cases are documented. Onset of this disease initiates outside of the CNS through activation of CD4 + T cells by myelin-like antigenic peptides. These cells then migrate across the blood-brain barrier initiating focal inflammation. Encephalitogenic T cells that invade the CNS interact with APCs, resulting in reactivation of the T cells and activation of the APCs (18) . Both IFN-g-secreting Th1 and IL-17-secreting Th (Th17) cells have been shown to have a pathogenic role in MS (19) and experimental autoimmune encephalomyelitis (EAE), the mouse model of MS (20, 21) , but an augment of circulating Th17 cells is often associated with active phases of the disease (22) , indicating a key role of Th17 cells in the exacerbation of the clinical symptoms.
To investigate the role of Hx in autoimmune inflammation, we studied the course of EAE induced by immunization of Hx knockout (Hx
2/2
) and syngenic wild-type mice with myelin oligodendrocyte glycoprotein peptide (MOG ). Our data show that in the absence of Hx, the clinical symptoms of EAE are more severe and earlier and are associated to a higher number of infiltrating and circulating Th17 cells. We also found that Hx has a crucial role in the differentiation of Th17 cells, and it is able to modulate the expression levels of Th17 prodifferentiating cytokines as IL-6 and IL-23.
Materials and Methods

Mice
Hx 2/2 mice on the 129/Sv background (H-2 b ) were previously described (23) . All mice were housed in our animal facility, with a 12-h dark/light *Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Turin, Italy; cycle and access to standard laboratory chow and tap water ad libitum. Sex-and age-matched wild-type mice on the 129/Sv background were used as controls. For all experiments, 6-to 8-wk-old male mice were used. Animal studies were approved by the animal ethical committee of the University of Turin, Turin, Italy. 
EAE in mice
Tissue histology and immunohistochemistry
Hx
2/2 and wild-type mice were sacrificed at day 28 after induction of EAE and perfused with 35 ml ice-cold PBS through the left ventricle. Spinal cords were isolated and fixed in 4% paraformaldehyde for 24 h, dehydrated in PBS-30% sucrose (Sigma) for 5 d, embedded in optimal cryopreserving tissue compound (OCT; Miles Laboratories, Elkhart, IN), snap-frozen, and sectioned transversally (7 mm/section). Sections were stained with H&E. High-resolution images of sections were captured at 3100 magnification using an Olympus BH-2 microscope, coupled to an Olympus camera. The total cell infiltration (inflammatory index) was assessed as follows: each spinal cord section was subdivided into 16 areas, and each subdivided area displaying lymphocyte infiltration was assigned a score of 1; thus, each animal had a potential maximum score of 16. Four sections of the lumbar spinal cord per animal were analyzed. The presence of CD4 + cells was evaluated by immunofluorescence: sections were incubated 1 h at room temperature with rat anti-mouse CD4-FITC diluted 1:100 (Biolegend, San Diego, CA); Hoechst (Invitrogen, Carlsbad, CA) was used to stain the nuclei. High-resolution images of sections were captured at 2003 magnification on a Zeiss fluorescence microscope (Zeiss, Thornwood, NY) with Zeiss ApoTome image visualization system. The number of CD4 + infiltrated cells in four consecutive sections of the lumbar spinal cord of four wild-type and four Hx 2/2 mice was blindly assessed. Evaluation of demyelization was performed by immunohistochemistry. Sections were incubated overnight with a rat anti-mouse myelin basic protein (MBP) Ab (Abcam, Cambridge, U.K.), diluted 1:100, followed by biotin-conjugated secondary Ab. The sections were visualized on an Olympus BH-2 microscope, coupled to an Olympus camera. As a control of the primary Ab specificity, serial sections were always processed in parallel with the secondary Ab alone.
Sera analysis
Serum was collected from the tail vein at day 0 and at days 2, 4, 7, 14, and 28 after immunization. One microliter of serum was separated on 10% NaDodSO 4 -PAGE and analyzed by Western blotting using an anti-Hx Ab (mAb 3D6/E12) (1). An anti-mouse IgG Ab (Abcam) was used as control. Alternatively, red Ponceau staining was used as loading control. Membranes were then incubated with 1:5000 HRP-conjugated anti-mouse IgG (Abcam) and revealed by ECL on a ChemiDoc system (Bio-Rad Laboratories, Segrate, Italy). Quantification of proteins was performed by densitometry analysis. IL-6 content in the sera was measured by ELISA kit (Biolegend).
Lymphocyte isolation
To isolate spinal cord and brain infiltrates, we sacrificed Hx 2/2 and wildtype mice at days 14 or 28 after induction of EAE, and we performed perfusion with 35 ml ice-cold PBS through the left ventricle. Spinal cords and brains were dissected out and digested with 2.5 mg/ml collagenase D (Roche, Mannheim, Germany) for 45 min at 37˚C. The tissue was homogenized in cold PBS, and the tissue suspensions were passed through a 70-mm cell strainer to obtain a single-cell suspension and then centrifuged. Cells were resuspended in 37% Percoll (GE Healthcare Europe GmbH, Milan, Italy) and overlaid with 70% Percoll. After centrifugation at 1000 3 g for 25 min, the cell monolayer at the 70-37% interphase was collected, washed in RPMI 1640 (Invitrogen), and used for flow cytometry. Spleens and lymph nodes (LNs) were collected from mice at day 0 and at days 7 and 14 of EAE, harvested, and single-cell suspensions were prepared by passage through a 70-mm cell strainer. Blood from Hx 2/2 and wild-type mice at days 7, 14, 21, and 28 after EAE induction was collected in heparinized tubes, and PBMCs were isolated by Ficoll (EuroClone, Pero, Italy) gradient.
Flow cytometry
Spinal cord and brain mononuclear cells, LNs cells, spleen cells (SPCs), and PBMCs were cultured in 48-well plates (1 3 10 6 cells/well) and activated with 50 ng/ml PMA (Sigma), 500 ng/ml Ionomycin (Sigma), and 10 ng/ml brefeldin A (Sigma) for 18 h. Cells were then harvested, washed in PBS-1% BSA, and labeled on the surface with FITC anti-mouse CD4 mAb (Biolegend). Cells were then washed and fixed in 4% paraformaldehyde for 15 min at room temperature; after washing, cells were permeabilized with 5% saponin (Sigma) in PBS and labeled intracellularly with PerCP antimouse IL-17 (Biolegend) or PE anti-mouse IFN-g mAb (Biolegend), 20 min at 4˚C. Stained cells were acquired on a FACSCalibur and analyzed with CellQuest (BD Biosciences, Erembodegem, Belgium). Each plot represents the results from 50,000 events. To depict cytokine release in response to MOG , we cultured SPCs isolated at day 0 and at days 7 and 14 postimmunization with or without MOG (10 mg/ml) in 24-well plates (4 3 10 6 cells/well) for 10 d. After 3 d, IL-2 (1 ng/ml) and IL-23 (10 ng/ml) were added to the cultures and replaced every 3 d. At day 9, cells were activated with PMA, Ionomycin, and brefeldin A for 18 h to perform intracellular staining as previously described. The percentage of MOG -specific Th17 and Th1 cells was measured by flow cytometry subtracting the percentage of cells cultured in absence of MOG . For the measurement of cytokine production, cells were cultured with MOG peptide for 48 h and supernatants tested by using an ELISA kit (Biolegend).
Th17 cell differentiation
Spleens were collected from Hx 2/2 and wild-type untreated mice, and single-cell suspensions were prepared by passage through a cell strainer (BD Biosciences). CD4 + naive cells were positively isolated by anti-CD4 and anti-CD62L microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany), and 2 3 10 6 CD4 + naive cells were cultured in 24-well plates, coated with 2 mg/ml anti-CD3 mAb and 2 mg/ml anti-CD28 (BD Biosciences) in the presence of Th17 prodifferentiating cytokines, 50 ng/ml IL-6 (Peprotech, Rocky Hill, NJ), 5 ng/ml TGF-b (Peprotech), and 10 ng/ml IL-23 (R&D Systems, Abingdon, U.K.), with or without IFN-g blocking Ab.
Supernatants were collected after 48 h and IL-17 production was measured by using an ELISA kit (Biolegend). Lymphocytes of the negative fraction were used as memory cells and cultured with or without 10 mg/ml IL-23 plus IFN-g blocking Ab.
Cell proliferation
Spleen cells were harvested and single-cell suspensions were prepared by passage through a cell strainer (BD Biosciences, Erembodegem, Belgium). Splenocytes were cultured in triplicate in round-bottom 96-well plates in the absence or presence of different concentrations of MOG peptide (0, 1, 10, 100 mg/ml). After 48 h, the cultures were pulsed with 1 mCi 
Quantitative real-time PCR analysis
Macrophages and dendritic cells were separated from spleens collected at day 0 and at day 7 after EAE induction using anti-F4/80 and anti-CD11c microbeads, respectively, following the manufacturer's instructions (Miltenyi Biotec). Total RNA was extracted from cells using RNeasy mini kit (Qiagen, Milan, Italy). cDNA was prepared from 1 mg total RNA using Promega M-MLV Retro Transcriptase (Promega Italia, Milan, Italy). Quantitative real-time (qRT)-PCR was performed on a 7300 Real Time PCR System (Applied Biosystems, Foster City, CA). Primers and probes were designed using the ProbeFinder software (http://www.roche-applied-science. com). All results were normalized to 18S mRNA.
Statistical analyses
Statistical analyses were performed with GraphPad Prism (GraphPad Software, San Diego, CA) by using one-way or two-way ANOVA, or the nonparametric two-tailed Mann-Whitney U test. A p value ,0.05 was considered significant.
Results
Hx is upregulated during EAE
To understand whether Hx was modulated during EAE in mice, we first analyzed its expression in the liver of wild-type mice before and at day 7 after the immunization with MOG peptide. Hx mRNA levels increased in wild-type liver at day 7 postinjection (Fig. 1A) . Moreover, we analyzed Hx in the serum of wild-type mice collected before and at days 2, 4, 7, 14, and 28 after MOG peptide immunization. As shown in Fig. 1B and 1C , Hx levels increased by day 2 after immunization and remained high until day 14. In addition, Hx expression was also upregulated in the CNS of wild-type mice with EAE (Supplemental Fig. 1 ). Thus, Hx is induced during murine EAE.
Loss of Hx exacerbates EAE disease
To investigate whether Hx modulates the autoimmune response, we examined the effects of Hx deficiency on the development of EAE. Disease progression was analyzed in wild-type and Hx 2/2 mice at different time points after immunization with MOG peptide.
In wild-type mice, the initial signs of EAE were observed 11.6 6 1.9 d after immunization ( Fig. 2A, 2B ). In contrast, in Hx
mice, the onset of EAE occurred on day 7.7 6 1.3 ( Fig. 2A, 2B 
4A-C).
Then the response of lymphocytes after in vitro stimulation with MOG was investigated. SPCs were isolated at day 0 and at days 7 and 14 after immunization, cultured for 10 d in the presence of 10 mg/ml MOG 35-55 peptide, and then checked for the cytokine profile. As shown in Fig. 4D 5C, 5D ). IL-12 expression did not change during disease and was comparable between Hx 2/2 and wild-type mice (Fig. 5C, 5D ).
Consistent with these data, the amount of IL-6 in the sera was higher in Hx 2/2 mice than in wild-type controls (Fig. 5E) . Finally, in the brain of Hx 2/2 mice, IL-6 and, to a lesser extent, IL-23 mRNA were significantly higher than in that of wild-type animals at day 28 postimmunization (Fig. 5F ). These results indicate that both intrinsic and extrinsic factors may contribute to the expansion of Th17 cells in Hx 2/2 mice. mice (Fig. 6B) . The amount of circulating Th17 cells (Fig. 6C) during disease progression as well as the amount of infiltrated Th17 cells in the spinal cord and in the brain (Fig. 6D ) at day 28 of EAE were significantly reduced in Hx-injected Hx 2/2 mice and were comparable with those of wild-type animals. As expected, the amount of circulating (Fig. 6C) and infiltrated (Fig. 6D ) Th1 cells were not affected by Hx injection.
Injection of purified Hx in Hx
As shown in Fig. 6E , the expression of IL-6 and IL-23 in the CNS at day 28 of EAE was reduced in Hx-injected Hx 2/2 mice compared with untreated Hx 2/2 animals and was similar to that of wild-types.
These data indicate that a single dose of Hx in Hx 2/2 mice was able to limit Th17 cell expansion, thus controlling EAE severity.
Discussion
In this study, we demonstrated that Hx affects the severity of EAE by limiting the expansion of the Th17 cell population. This 
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by guest on April 13, 2017 http://www.jimmunol.org/ conclusion comes from the observation that Hx 2/2 mice developed a more severe and earlier EAE than wild-type animals, associated with a higher amount of circulating and infiltrating Th17 cells autoreactive against myelin. A direct effect of Hx in controlling EAE development is further demonstrated by the "rescue experiment" in which Hx administration in Hx 2/2 mice before EAE induction has been shown to limit Th17 cell expansion and attenuate disease severity. Both Th1 and Th17 cells have been defined as effector T cell subsets involved in the pathogenesis of the EAE, but Th17 cells are considered to be more pathogenic than Th1 cells (24) . Autoantigen-specific Th17 cells have been shown to break and transmigrate across the blood-brain barrier, and in the CNS induce inflammation by neutrophil recruitment (20) and killing of neurons (25) . Thus, the more severe EAE developed by Hx 2/2 mice may be ascribed to the higher amount of Th17 cells infiltrating the CNS and circulating in the periphery of Hx 2/2 mice compared with wild-type controls. The Th17-driven EAE developed by Hx 2/2 mice is due to both intrinsic and extrinsic factors. We showed that CD4 + T cells isolated from Hx 2/2 mice polarize more efficiently toward Th17 lineage than cells isolated from wild-types controls. The absence of Hx seems to predispose naive CD4 cells to differentiate into Th17 lineage as CD4 + naive cells from Hx 2/2 mice produce an enhanced amount of IL-17 compared with the same cells from wild-type mice. By contrast, activated memory CD4 cells produce The enhanced potential of CD4 + naive T cells to differentiate toward Th17 lineage might be because of the reduced sensitivity to IFN-g of lymphocytes of Hx 2/2 mice as we previously demonstrated that, in the absence of Hx, T cells displayed a reduced IFN-g-STAT1-dependent phosphorylation (26) . IFN-g signaling plays a key role in Th17 differentiation and function (27) . It was already demonstrated that the neutralization of IFN-g effect by a specific mAb to IFN-g or to the IFN-gR1 chain was required for the massive development of activated T lymphocytes cultured in the presence of IL-23 into Th17 cells (28) . The Hx-mediated control of CD4 + T cell responsiveness to IFN-g might be related to the Hx ability to modulate iron availability within cells (1), thus affecting the expression of Transferrin receptor that has already (12) . It has already been shown that Hx was able to downregulate the secretion of IL-6 and TNF-a from macrophages in response to LPS in a manner that is distinct from its function as a heme scavenger (12) . This might occur by limiting TLR4-and TLR2-induced cytokine production. TLR signals, induced by pathogen-associated molecular patterns contained in the CFA, are necessary for the induction of EAE and influence the CD4 Th cell-dependent inflammation that causes EAE (34) . Absence of TLR4 exacerbates EAE and is associated with increased expression of IL-6 and IL-23 in splenic dendritic cells and increased frequency of Th17 cells (35) . By contrast, deficiency of TLR2 in CD4 + T cells substantially impaired Th17 response in vivo and the pathogenesis of EAE (36) . In this article, we show that Hx is able to modulate not only the secretion of IL-6, but also that of IL-23, an effect similar to that obtained by TLR4 blockade (35) , confirming the emerging hypothesis that Hx may modulate the response to TLR4 and TLR2 ligands, thus playing a role in acute and chronic inflammatory diseases (12, 13) . The elucidation of the mechanisms by which Hx could modulate TLR activity needs more studies.
Hx was reported to be produced in the CNS by ependymal cells, neurons, and glial cells (1, 2, 4, 5) . In the CNS, Hx controls iron accumulation in oligodendrocytes and affects their differentiation (4, 37) . Accordingly, the expression of the MBP along with the density of myelinated fibers in the basal ganglia and in the motor and somatosensory cortex of Hx 2/2 mice was strongly reduced compared with wild-type controls (37). Thus, it is possible that the exacerbated demyelination we observed in Hx 2/2 mice with EAE was due not only to massive Th17 cell infiltration, but also to the impairment of Hx-deficient oligodendrocytes to respond to exogenous insults. This conclusion is consistent with data showing that iron deposition in the brain contributes to MS pathogenesis (38) . Thus, Hx would control, on one hand, systemic signals driving Th17 differentiation and, on the other hand, local signals in CNS affecting oligodendrocyte function. Hx has been reported to be induced in pediatric MS (14) . Our data on Hx 2/2 mice with EAE may give an explanation to such induction. Hx upregulation is expected to contribute to the inflammatory response thus controlling the severity of the disease. Moreover, by controlling T cell responsiveness to IFN-g, Hx induction might limit Th17 cell differentiation. Results obtained by injecting purified Hx in Hx 2/2 mice strongly support these conclusions. Finally, the previously reported observation that Hx expression in CNS controls oligodendrocyte function suggests that all of these factors may contribute to disease establishment and progression. Thus, Hx administration may be beneficial in clinical settings, such as autoimmune and inflammatory diseases, characterized by dysregulation of T cell differentiation. 
THE ACUTE-PHASE PROTEIN HEMOPEXIN IS A NEGATIVE REGULATOR OF TH17 RESPONSE AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMIELITIS
